Saudi Arabia vs Tanzania, United Republic of: Access to anti-retroviral drugs, female
Saudi Arabia
91.0%
in 2024
Tanzania, United Republic of
90.0%
in 2024
Saudi Arabia rank
25th
Tanzania, United Republic of rank
27th
Access to anti-retroviral drugs, female over time
- Saudi Arabia
- Tanzania, United Republic of
How they compare
Saudi Arabia currently reports 91.0% against 90.0% in Tanzania, United Republic of, a difference of 1.0%.
Across all 25 years both countries report, Saudi Arabia has been ahead every year.
Saudi Arabia ranks 25th and Tanzania, United Republic of ranks 27th of 141 countries.
Saudi Arabia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Saudi Arabia | Tanzania, United Republic of | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 24.3% | 4.7% | 19.6% | Saudi Arabia |
| 2010s | 62.5% | 44.5% | 18.0% | Saudi Arabia |
| 2020s | 83.2% | 78.0% | 5.2% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Saudi Arabia or Tanzania, United Republic of?
- Saudi Arabia, at 91.0% against 90.0% in Tanzania, United Republic of as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Saudi Arabia and Tanzania, United Republic of?
- 1.0%, with Saudi Arabia ahead.
- How many years of comparable data are there for Saudi Arabia and Tanzania, United Republic of?
- 25 years are reported by both, from 2000 to 2024.
- How do Saudi Arabia and Tanzania, United Republic of rank globally for access to anti-retroviral drugs, female?
- Saudi Arabia ranks 25th and Tanzania, United Republic of ranks 27th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.